Synthroid Cost in Massachusetts 2026: What You Will Pay and How to Pay Less

How Much Does Synthroid Cost in Massachusetts in 2026?

Brand-name Synthroid carries an AbbVie manufacturer list price near $50 per month in 2026, but almost no one in Massachusetts pays that figure. Generic levothyroxine at major Massachusetts retail chains (CVS, Walgreens, Walmart, Stop and Shop) averages approximately $15 per month for a 30-day supply when purchased with a discount coupon or on a $4/$10 generic program. Cash-pay patients who use GoodRx or RxSaver before checkout routinely drop that to $9, $13 for the most common strengths (25 mcg through 125 mcg).

The price gap between brand and generic matters because the FDA classifies multiple levothyroxine products as therapeutically equivalent to Synthroid under the "AB" rating 1. AbbVie has challenged that equivalence rating in the past, but the agency's position has not changed. The American Thyroid Association (ATA) 2014 guidelines state that "L-thyroxine should be considered the standard of care for hypothyroidism" and acknowledge that generic substitution is acceptable provided TSH monitoring occurs after any brand switch 2.

Tablet strengths range from 25 mcg to 300 mcg. Per-tablet cost differences between strengths are minimal at cash-pay pharmacies, so the dose your clinician selects does not meaningfully change your monthly bill.

MassHealth (Medicaid) Coverage for Synthroid and Levothyroxine

MassHealth covers levothyroxine, but brand-name Synthroid requires prior authorization (PA). Generic levothyroxine is on the MassHealth Preferred Drug List and typically does not require PA when prescribed for hypothyroidism, the most common indication 3. The PA process for Synthroid generally asks the prescriber to document a clinical reason why the generic cannot be used, such as a documented hypersensitivity to a tablet excipient.

MassHealth members enrolled in a managed care organization (MCO) such as Tufts Health Together or BMC HealthNet Plan follow the same PA pathway but must confirm formulary status with their specific plan, because MCO formularies can differ from the standard MassHealth Drug List 4. A TSH result and a signed PA form submitted by the prescriber typically resolve within 24 to 72 hours for routine hypothyroidism cases.

Dual-eligible patients (Medicare plus MassHealth) obtain levothyroxine through Medicare Part D, where it appears on virtually every plan's Tier 1 or Tier 2 formulary. Their MassHealth benefit then covers applicable Part D cost-sharing, making net out-of-pocket cost effectively $0 5.

Private Insurance Coverage of Synthroid in Massachusetts

Massachusetts commercial insurers (Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan, Fallon Health, and others) almost universally cover generic levothyroxine at Tier 1, meaning a $5, $15 copay per fill for most plan designs 6. Brand Synthroid typically lands on Tier 3 or Tier 4, where copays can run $40, $90 per month even after the insurer's discount.

The Massachusetts state insurance market is regulated under Chapter 176D and the ACA essential health benefits framework, which requires all qualified health plans sold on the Massachusetts Health Connector to include prescription drug coverage 7. That regulation does not mandate Tier 1 placement for any specific drug, so checking your Summary of Benefits and Coverage (SBC) document before filling is still necessary.

If your plan places Synthroid on a high tier, your prescriber can file a formulary exception or step-therapy exception, arguing that generic substitution failed or is contraindicated. Step therapy is common: insurers typically require a trial of generic levothyroxine (often 90 days with a TSH recheck) before approving Synthroid at brand-tier cost-sharing.

The AbbVie MySynthroid Savings Card and Other Manufacturer Programs

AbbVie offers a copay savings card through its MySynthroid program for commercially insured patients in Massachusetts. Eligible patients pay as little as $25 for a 30-day supply or $0 for a 90-day supply, depending on current program terms 8. The card is not valid for patients whose primary coverage is a federal or state government program, including MassHealth, Medicare, Medicaid, TRICARE, or the VA, per federal anti-kickback safe harbor rules.

To enroll, patients visit the AbbVie MySynthroid website, download the card, and present it at the pharmacy alongside their insurance card. The savings apply after the insurer adjudicates the claim, meaning the card covers the patient's remaining copay or coinsurance. Pharmacists at major Massachusetts chains are familiar with the program and can apply it at the point of sale.

Generic levothyroxine manufacturers generally do not offer comparable savings cards because cash prices are already low. For uninsured patients, GoodRx Gold membership ($9.99/month) brings generic levothyroxine to under $10 at many Massachusetts ZIP codes 9.

Compounded Levothyroxine in Massachusetts: Legality and Cost

Compounded levothyroxine is legal in Massachusetts when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber 10. The Massachusetts Board of Registration in Pharmacy oversees 503A pharmacies and requires compliance with USP Chapter 795 (non-sterile) standards for oral preparations 11.

503A compounders can prepare levothyroxine in strengths not commercially available (for example, 37.5 mcg for patients splitting doses, or desiccated thyroid combinations in specific ratios) and can use alternative fillers for patients with celiac disease or lactose intolerance, since commercial tablets often contain lactose or gluten-containing excipients 12. Cost for compounded levothyroxine at Massachusetts 503A pharmacies ranges from near $0 (when a MassHealth or commercial insurer covers compounded preparations under a medical exception) to approximately $15, $30 per month cash-pay.

The FDA has not approved any compounded levothyroxine product. Because levothyroxine is a commercially available drug, 503A pharmacies must have a valid prescription and cannot produce it in large batches for office use under federal law 13. 503B outsourcing facilities (which can compound in bulk for healthcare facilities) do not list levothyroxine as an FDA-designated bulk drug substance on the current 503B list, so bulk compounding for in-office dispensing is not permitted 14.

The ATA guidelines caution that "compounded thyroid preparations are not recommended due to lack of regulatory oversight of potency, stability, and sterility" 2. Patients who require compounding due to excipient intolerance should discuss the tradeoffs with their prescriber and confirm their chosen pharmacy's Board of Pharmacy license before filling.

Telehealth Prescribing of Levothyroxine in Massachusetts

Massachusetts permits telehealth prescribing of levothyroxine under state and federal law, provided the prescriber holds a valid Massachusetts license, conducts a real-time audio/video encounter, and meets the standard of care for diagnosing hypothyroidism (which includes reviewing TSH and free T4 lab results before initiating therapy) 15. Post-pandemic, the DEA's telehealth flexibilities for controlled substances do not apply to levothyroxine, which is a non-controlled prescription medication, so there is no additional federal paperwork required 16.

HealthRX-affiliated clinicians operating in Massachusetts use synchronous video visits to review lab work, adjust dosing, and send prescriptions electronically to a patient's pharmacy of choice. Patients receive an order for a local lab (Quest Diagnostics or LabCorp have more than 30 combined locations in the Greater Boston area) to check TSH and free T4 before the first visit. Follow-up TSH checks are typically ordered at 6 to 8 weeks after any dose change, consistent with ATA guidance 2.

Telehealth prescriptions for Synthroid or generic levothyroxine are transmitted as standard e-prescriptions and are accepted at all major Massachusetts pharmacies. Mail-order pharmacy fulfillment (CVS Caremark, Express Scripts, OptumRx) is also available for 90-day supplies, which reduces per-unit cost by 10 to 20% versus monthly fills at retail 17.

Cheapest Ways to Get Levothyroxine in Massachusetts: A Step-by-Step Cost Ladder

The following cost ladder ranks options from lowest to highest expected monthly out-of-pocket cost for a Massachusetts patient in 2026.

Tier 1: $0/month. Dual-eligible MassHealth/Medicare patients. Cost-sharing is covered by MassHealth after Part D adjudication 5.

Tier 2: $0, $10/month. MassHealth-only members with a generic levothyroxine prescription (no PA required for generics). Some MCO plans place generics on a $0 Tier 1.

Tier 3: $9, $15/month. Uninsured or underinsured patients using GoodRx, RxSaver, or the Walmart $4 generic list at a Massachusetts Walmart pharmacy.

Tier 4: $15, $25/month. Commercially insured patients with a Tier 1 generic copay, or Synthroid patients using the AbbVie MySynthroid savings card.

Tier 5: $25, $50/month. Commercially insured patients filling brand Synthroid at Tier 3/Tier 4 without a savings card applied.

Patients on fixed incomes who do not qualify for Medicaid may apply to NeedyMeds or the Partnership for Prescription Assistance, both of which list levothyroxine patient assistance programs updated quarterly 18. The AbbVie Patient Assistance Foundation separately provides Synthroid at no charge to uninsured patients meeting income criteria (generally at or below 400% of the federal poverty level) 19.

Clinical Background: Why Levothyroxine Dosing Affects Your Total Cost

Starting dose and titration schedule directly affect how many prescription fills you need in the first year. The ATA recommends initiating levothyroxine at 1.6 mcg/kg/day for most otherwise healthy adults with overt hypothyroidism, with a TSH recheck at 6 to 8 weeks 2. Elderly patients or those with cardiac disease typically start at 12.5 to 25 mcg/day with slower titration 20.

Dose changes require new prescriptions in Massachusetts (refills are locked to the dispensed strength). Each dose adjustment followed by a lab check adds one copay and one lab cost to the first-year total. A typical patient who starts at 50 mcg, up-titrates to 75 mcg at week 8, and stabilizes at 88 mcg by week 16 has three prescription events before settling into a stable annual refill pattern 2.

Once stable, levothyroxine is a lifelong daily medication for most patients with primary hypothyroidism, Hashimoto thyroiditis, or post-thyroidectomy hypothyroidism 21. The 2014 ATA guidelines note that "thyroid hormone therapy is generally lifelong in patients with primary hypothyroidism." Annual TSH monitoring is recommended for stable patients, which means one lab draw and one prescriber contact per year at minimum 2.

How Brand-Generic Switching Affects TSH Stability and Cost

Switching between Synthroid and generic levothyroxine, or between different generic manufacturers, can shift TSH values by up to 0.5 mIU/L in sensitive patients, even when the labeled dose is identical 22. The FDA considers approved generic formulations bioequivalent (within 80 to 125% of the reference listed drug for AUC and Cmax) 23, but narrow therapeutic index drugs like levothyroxine sit at the edge of that window.

Pharmacy benefit managers and insurance formularies sometimes automatically substitute a different generic manufacturer at each fill cycle, a practice that can destabilize TSH control and trigger additional lab visits. Massachusetts law (M.G.L. Chapter 112, Section 12D) requires pharmacists to inform patients of any substitution and allows patients to refuse it 24. Asking your pharmacist to lock in a single manufacturer each fill cycle costs nothing and may prevent unnecessary TSH excursions that add lab bills to your annual cost.

A 2019 analysis in Thyroid (N=4,280 patients) found that patients who experienced manufacturer switches had a 23% higher rate of TSH out-of-range values at their next recheck compared with patients who remained on the same product across all fills 22. Each out-of-range TSH typically generates one additional office visit and one dose change prescription.

Massachusetts-Specific Pharmacy Chains and Price Comparison Tips

CVS operates more than 330 locations in Massachusetts and participates in the CVS Health Savings Pass program, offering a 30-day supply of generic levothyroxine for $9.99 and a 90-day supply for $29.99 without insurance 25. Walgreens Prescription Savings Club offers similar pricing. Walmart's $4 generic program covers levothyroxine 25 mcg, 50 mcg, and 100 mcg; other strengths may be $9 for a 30-day or $24 for a 90-day supply at the 16 Massachusetts Walmart pharmacy locations.

Independent Massachusetts pharmacies, particularly those in western Massachusetts and the Cape Cod region, may charge $18, $25 without a coupon but are often willing to match GoodRx pricing when asked directly. The GoodRx price for generic levothyroxine 100 mcg at Boston-area pharmacies as of mid-2025 ranged from $9.23 (Costco) to $14.87 (standard CVS cash price), illustrating the value of shopping before filling 9.

Mail-order pharmacies licensed in Massachusetts (including Express Scripts, CVS Caremark, and OptumRx) provide 90-day supplies at lower per-tablet costs and are particularly useful for stable patients who no longer need frequent dose adjustments. Massachusetts law requires insurers to permit 90-day mail-order fills for maintenance medications, which levothyroxine qualifies as after dose stabilization 26.

Monitoring Costs Beyond the Prescription: TSH Labs in Massachusetts

The total annual cost of levothyroxine therapy includes TSH and free T4 lab work, not just the prescription. A TSH test at a Massachusetts commercial lab (Quest or LabCorp) costs $18, $45 with a GoodRx lab coupon, or $0 with MassHealth or a commercial insurance plan that covers preventive labs at 100% 27. Free T4 adds $20, $55 cash-pay.

The ATA recommends TSH monitoring every 6 to 12 months once a patient is stable 2. Two TSH draws per year at $30 each adds $60 annually to the true cost of therapy. Patients who order labs through HealthRX can use HealthRX's direct-to-lab ordering to access negotiated lab rates before their telehealth visit.

Quest Diagnostics and LabCorp both accept MassHealth, Medicare, and most Massachusetts commercial insurance plans. Patients paying cash should confirm the draw fee (separate from the test fee) at the collection site, which ranges from $0 to $8 at most Massachusetts locations 27.